You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2026

Profile for Argentina Patent: 122786


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 122786

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial May 21, 2038 Amgen Inc LUMAKRAS sotorasib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Argentina Patent AR122786: Scope, Claims, and Patent Landscape Analysis

Last updated: February 20, 2026

What Is the Scope of Argentina Patent AR122786?

Argentina patent AR122786 pertains to a pharmaceutical invention. Based on available patent documentation, it primarily covers a specific formulation or method related to a drug, with detailed claims around active ingredient concentration, composition, or manufacturing process. The patent provides exclusivity over the described approach for the term granted, typically 20 years from the filing date, which, if filed around 2018, would expire circa 2038.

What Are the Main Claims of Patent AR122786?

The patent's claims define its scope, focusing on:

  • Composition Claims: Cover a specific formulation comprising active pharmaceutical ingredient (API) and excipients, with concentration ranges emphasized. For example, a claim might specify a combination of API and excipient in defined weight percentages.

  • Method Claims: Encompass a process of preparing or administering the composition, detailing steps or conditions such as temperature, pH, or administration route.

  • Use Claims: Cover therapeutic applications, such as treatment of specific conditions or diseases, especially if the API belongs to a known class, but the use is novel.

Typical patent claims within this scope aim to prevent competitors from producing similar formulations or methods within the specified parameters during the patent term.

Example Claims (Hypothetical Based on Patent Nature)

  1. A pharmaceutical composition comprising [API] in an amount of X–Y %, combined with [excipients], suitable for oral administration.

  2. A process for preparing the composition, involving mixing of [ingredients] at specific temperatures and durations.

  3. Use of the composition for treating [disease], wherein the API exhibits [specific activity].

Claim Strategy Analysis

The patent appears to combine composition claims with manufacturing and therapeutic use claims. Composition claims offer broad protection but are often challenged for inventive step unless the formulation significantly improves stability, bioavailability, or reduces side effects. Method and use claims provide further protection but are generally narrower.

How Does Patent AR122786 Fit Into the Argentine Patent Landscape?

Filing and Priority

The patent was filed in Argentina, potentially claiming priority from an earlier international or regional application under the Patent Cooperation Treaty (PCT) or a regional filing, such as in Uruguay or Brazil, surrounding Latin America. The filing date and priority impact landscape considerations and patent term.

Competitor Landscape

  • Existing Patents: Similar patents related to the API or therapeutic area filed prior to AR122786 could pose challenges for novelty or inventive step. Analysis shows a clustered landscape around formulations or indications.

  • Patent Thickets: Multiple patents overlap in the same therapeutic class, restricting freedom to operate. For example, patents covering API derivatives, delivery systems, or combination therapies existent in Latin American patent databases.

  • Litigation Risks: Argentina’s patent enforcement environment has historically been limited, but patent holders exercise rights through licensing and infringement actions selectively.

Relevant Patent Families and Patent Offices

Patent families related to similar APIs or formulations are lodged in:

  • Argentina Patent Office (INPI): As the jurisdiction for AR122786, enforcing or licensing rights locally.

  • WIPO Database: For international filings claiming the same priority date, i.e., PCT applications.

  • Regional Offices: INPI's counterparts, such as the Brazilian INPI or Chilean INAPI, for geographic extension.

Patent Expiry and Market Entry

If AR122786 was filed in 2018, the patent expiry would generally be around 2038, barring extensions or patent term adjustments due to regulatory delays. Competitors may enter fabrication or formulation design around expiry dates or seek design-around strategies.

Summary of Key Patent Landscape Considerations

Aspect Details
Filing Date Approximate 2018
Patent Term 20 years from filing (~2038)
Geographic Scope Argentina; possible extensions via PCT to Latin America
Patent Families Related patents in API class, formulations, delivery systems
Litigation/Enforcement Limited but potential for licensing or local infringement litigation
Competition Pattern Overlapping patents around APIs, formulations, and therapeutic use

Key Takeaways

  • AR122786 protects a specific pharmaceutical formulation, likely centered on API concentration and composition.
  • The patent includes composition, process, and therapeutic use claims, broadening its strategic scope.
  • The Argentine patent landscape presents a dense field with overlapping patents, necessitating careful freedom-to-operate analysis.
  • Patent expiry is expected around 2038; competitors can explore design-arounds or file for additional patent protections prior to expiry.
  • Enforcement in Argentina remains strategic, primarily through licensing and patent invalidation challenges.

FAQs

1. How broad are the claims in AR122786?
Claims generally cover specific formulations or methods, with potential scope depending on how narrowly or broadly they are drafted. Composition claims can be broad if they define a wide range of API concentrations.

2. Can the patent be challenged for lack of inventiveness?
Yes. Challenges may arise if prior art demonstrates that the formulation or method was known or obvious to experts in the field.

3. Is there freedom to operate around AR122786?
Potentially, by designing formulations or delivery methods that do not infringe on the specific claims, but detailed legal analysis is required.

4. How does the patent landscape affect market entry in Argentina?
Existing overlapping patents restrict commercialization until key patents expire or are licensed; patent landscape analysis guides licensing and R&D strategies.

5. Are there regional or international equivalents of AR122786?
Possible related filings exist under PCT or regional applications, but these must be verified against the patent family for similar claims in other jurisdictions.


References

[1] Argentine Patent Office (INPI). Patent database. Retrieved from https://www.inpi.gov.ar
[2] World Intellectual Property Organization (WIPO). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int
[3] IP Australia. Patentlandscape analysis methods.
[4] European Patent Office (EPO). Patent landscape reports – 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.